Medium/Large Size Posterior Uveal Melanoma

specific

Ciliary body and choroid melanoma measuring between 2.5 mm and 10 mm in height and 16 mm or less in basal diameter (medium-sized) or more than 10 mm in height or more than 2 mm in height and more than 16 mm in basal diameter or more than 8 mm in height with optic nerve involvement (large-sized). (Collaborative Ocular Melanoma Study)

Centers

Active Trials

—

Cancer Funding

Top Centers for Medium/Large Size Posterior Uveal Melanoma(44)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	51.1
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	51.1
3	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive	—	—	51.1
4	Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive	—	—	51.1
5	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive	—	—	51.1
6	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive	—	—	51.1
7	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive	—	—	51.1
8	UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive	—	—	51.1
9	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	51.1
10	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	—	51.1
11	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive	—	—	51.1
12	Winship Cancer InstituteAtlanta, GA NCI Comprehensive	—	—	51.1
13	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive	—	—	51.1
14	City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive	—	—	51.1
15	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	51.1
16	Moffitt Cancer CenterTampa, FL NCI Comprehensive	—	—	51.1
17	Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive	—	—	51.1
18	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	51.1
19	UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive	—	—	51.1
20	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	51.1
21	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	—	51.1
22	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	51.1
23	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	51.1
24	Cleveland Clinic Cancer CenterCleveland, OH	—	—	51.1
25	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	51.1
26	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	51.1
27	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive	—	—	51.1
28	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive	—	—	51.1
29	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive	—	—	51.1
30	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	—	51.1
31	University of Illinois Cancer CenterChicago, IL	—	—	51.1
32	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive	—	—	51.1
33	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR	—	—	51.1
34	Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive	—	—	51.1
35	Boston University Cancer CenterBoston, MA	—	—	51.1
36	Karmanos Cancer InstituteDetroit, MI NCI Comprehensive	—	—	51.1
37	Cancer Center at IllinoisUrbana, IL	—	—	51.1
38	Stony Brook Cancer CenterStony Brook, NY	—	—	51.1
39	University of Cincinnati Cancer CenterCincinnati, OH	—	—	51.1
40	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL	—	—	51.1
41	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ	—	—	51.1
42	Georgia Cancer Center, Augusta UniversityAugusta, GA	—	—	51.1
43	The University of Vermont Cancer CenterBurlington, VT	—	—	51.1
44	Louisiana Cancer Research CenterNew Orleans, LA	—	—	51.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →